Form 4: CONMED Corp Executive Lalomia Acquires 18,988 Stock Options

Brent Lalomia, Vice President of QA and RA at CONMED Corp, acquired 18,988 stock options on March 1, 2024, under the company's 2018 Long-Term Incentive Plan.

Summary

• On March 1, 2024, Brent Lalomia, a Vice President at CONMED Corp, acquired 18,988 stock options.
• The options have an exercise price of $79.95.
• These options were granted under the company's 2018 Long-Term Incentive Plan.
• The options generally vest in equal amounts over a five-year period.
• The expiration date for the options is March 1, 2034.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to executive compensation. It is neutral in tone and does not contain any information that would significantly impact investor sentiment.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.

Industry Context

Stock option grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in the medical device industry, similar to companies like Medtronic, Stryker, and Johnson & Johnson.
• The vesting schedule of five years is also a common practice to ensure long-term commitment from the executive.

Key Dates